Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - a scoping review
<p><strong>Background:</strong> The limited supply of universal plasma has resulted in transfusion of ABO incompatible plasma to patients. As the need to implement whole blood transfusion in pre-hospitals setting rises, the lowest cut-off for anti-A/anti-B that does not cause haemo...
Main Authors: | McCullagh, J, Cardigan, R, Brunskill, SJ, Bullock, T, Doree, C, Estcourt, L, Huish, S, Sandercock, J, Green, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Similar Items
-
ABO-incompatible granulocyte transfusion: Is ABO subgroup a barrier?
by: Soma Agrawal, et al.
Published: (2022-01-01) -
ABO incompatible renal transplant: Transfusion medicine perspective
by: Raj Nath Makroo, et al.
Published: (2017-01-01) -
Universal irradiation of platelets: does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?
by: Cain, L, et al.
Published: (2024) -
The difference in potential harms between whole blood and component blood transfusion in major bleeding: A rapid systematic review and meta-analysis of RCTs
by: Geneen, LJ, et al.
Published: (2021) -
ABO incompatibility hemolytic disease following exchange transfusion 96 newborn
by: Khatami S.F, et al.
Published: (2007-09-01)